1. Home
  2. ALLR vs AEHL Comparison

ALLR vs AEHL Comparison

Compare ALLR & AEHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLR
  • AEHL
  • Stock Information
  • Founded
  • ALLR 2004
  • AEHL 1993
  • Country
  • ALLR United States
  • AEHL China
  • Employees
  • ALLR N/A
  • AEHL N/A
  • Industry
  • ALLR Biotechnology: Pharmaceutical Preparations
  • AEHL Building Materials
  • Sector
  • ALLR Health Care
  • AEHL Industrials
  • Exchange
  • ALLR Nasdaq
  • AEHL Nasdaq
  • Market Cap
  • ALLR 15.8M
  • AEHL 13.9M
  • IPO Year
  • ALLR N/A
  • AEHL 2007
  • Fundamental
  • Price
  • ALLR $0.94
  • AEHL $3.34
  • Analyst Decision
  • ALLR Strong Buy
  • AEHL
  • Analyst Count
  • ALLR 1
  • AEHL 0
  • Target Price
  • ALLR $9.00
  • AEHL N/A
  • AVG Volume (30 Days)
  • ALLR 367.8K
  • AEHL 661.3K
  • Earning Date
  • ALLR 08-15-2025
  • AEHL 09-29-2025
  • Dividend Yield
  • ALLR N/A
  • AEHL N/A
  • EPS Growth
  • ALLR N/A
  • AEHL N/A
  • EPS
  • ALLR N/A
  • AEHL N/A
  • Revenue
  • ALLR N/A
  • AEHL $98,773,000.00
  • Revenue This Year
  • ALLR N/A
  • AEHL N/A
  • Revenue Next Year
  • ALLR N/A
  • AEHL N/A
  • P/E Ratio
  • ALLR N/A
  • AEHL N/A
  • Revenue Growth
  • ALLR N/A
  • AEHL 36.99
  • 52 Week Low
  • ALLR $0.61
  • AEHL $1.79
  • 52 Week High
  • ALLR $6.00
  • AEHL $143.20
  • Technical
  • Relative Strength Index (RSI)
  • ALLR 47.03
  • AEHL 52.83
  • Support Level
  • ALLR $0.85
  • AEHL $3.06
  • Resistance Level
  • ALLR $1.01
  • AEHL $3.87
  • Average True Range (ATR)
  • ALLR 0.05
  • AEHL 0.48
  • MACD
  • ALLR -0.01
  • AEHL 0.04
  • Stochastic Oscillator
  • ALLR 47.55
  • AEHL 74.39

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

About AEHL Antelope Enterprise Holdings Limited

Antelope Enterprise Holdings Ltd operates in two reportable operating segments: 1) business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting, and 2) natural gas power generation, which was in the initial development stage. The business of the Company is engaged in the PRC and U.S.

Share on Social Networks: